Skip to content

Effects of Vit D3 and ultraviolet on the treatment of psoriasis

Comparison between the effects of Daivonex cream alone or together with narrowband ultra violet B on treatment of psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903294207N1
Enrollment
94
Registered
2013-11-07
Start date
2013-05-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis. Psoriasis

Interventions

Intervention 1: In Daivonex group patients will be asked to apply 0.5 mg of the cream on a palm-sized surface of the body twice a day for three months. Intervention 2: In Daivonex plus ultraviolet gro
plus, patients in the later group will be similarly treated with Daivonex and in the phototherapy days cream will be applied after phototherapy.
Treatment - Drugs
Treatment - Other
In Daivonex group patients will be asked to apply 0.5 mg of the cream on a palm-sized surface of the body twice a day for three months.
In Daivonex plus ultraviolet group patients will be treated using a phototherapy device, Dermapal 800 Davlin, USA, for 33 seconds twice a week with primary energy of 0.2 Joules per square centimeter f

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: (to have psoriasis with involved body surface area less than 10%; not to have photo-sensitivity; not to have another systemic disease; and not to have skin malignancies) Exclusion criteria: (pregnancy and lactating; having a positive drug history within the last month)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Erythema. Timepoint: Before the initiation of the treatment and 4, 8 and 12 weeks after the initiation of the treatment. Method of measurement: By physical examination.;Scaling. Timepoint: Before the initiation of the treatment and 4, 8 and 12 weeks after the initiation of the treatment. Method of measurement: By physical examination.;Lesion thickness. Timepoint: Before the initiation of the treatment and 4, 8 and 12 weeks after the initiation of the treatment. Method of measurement: By physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Ezzati

Tabriz University of Medical Sciences

abo.ezzati@yahoo.com+98 41 1541 2151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026